EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Enucleation for Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors Larger than 2 Centimeters Is Associated with Equivalent Morbidity and Survival Compared to Smaller Tumors: A Multi-Institutional Study

Elias Karam, Alexandra Nassar, Sara Elkurdi, Guillaume Péré, Thomas Freville, Edouard Wasielewski, Anaïs Palen, Julie Périnel, Jean-Christophe Lifante, Emilie Lermite, Ugo Marchese, Mustapha Adham und 7 weitere

Neuroendocrinology · 23.08.2024 · 114 (11) · 1034-1044

DOI: 10.1159/000541078 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Neuroendocrinology, online erschienen am 23.08.2024. Verfasst von Elias Karam und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Surgery and Liver Transplant, Tours University Hospital, Tours, France, eliasjrkaram@gmail.com. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Nonfunctioning pancreatic neuroendocrine tumor (NF-PanNET) ≤2 cm can be observed or resected. Surgery remains recommended for NF-PanNET >2 cm but its extent, enucleation (EN) versus formal resection, remains controversial.

Methods

Multicentric retrospective cohort of sporadic NF-PanNET patients treated with EN. Short- and long-term outcomes were compared according to tumor size on imaging ≤2 cm versus >2 cm.

Results

131 patients underwent EN for NF-PanNET, including 103 (79.0%) ≤2 cm and 28 (21.0%) >2 cm (extremes, 4–55 mm). Patients’ characteristics were comparable, and tumor characteristics only differed in their diameter. Clavien III-IV complications were similar (18.4% vs. 17.9%, p = 1.00) with one death in NF-PanNET ≤2 cm. Grade B/C pancreatic fistula were comparable (16.5% vs. 10.7%, p = 0.850). In NF-PanNET >2 cm there were more pT2/3 stage tumors (85.7% vs. 21.4%, p < 0.001), similar rates of grade G2/3 tumors (25% vs. 16.5%, p = 0.408) with a median Ki67 of 2 (interquartile range: 1–3), and of lymphovascular and perineural invasions. Lymph node picking was done in 46 (35.1%) patients, with a higher median number of harvested lymph nodes in NF-PanNET >2 cm (4 vs. 3, p = 0.01). All were pN0. R0 resection rate (78.6% vs. 82.5%, respectively; p = 0.670) was equivalent. Five-year overall (100% vs. 99%, p = 0.602) and 10-year disease-free (96% vs. 92%, respectively; p = 0.532) survivals were comparable.

Conclusions

EN for selected NF-PanNET >2 cm carries equivalent morbidity, overall and disease-free survivals compared to those observed with NF-PanNET ≤2 cm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultPancreatectomyNeuroendocrine TumorsTreatment Outcome

Stichwörter der Autor:innen

EnucleationNonfunctioning neuroendocrine tumorPancreatic surgeryParenchyma-sparing resection

Autor:innen und Institutionen

  • Department of Digestive Surgery and Liver Transplant, Tours University Hospital, Tours, France, eliasjrkaram@gmail.com.
  • Department of Digestive, Hepatobiliary and Endocrine Surgery, Cochin Hospital, AP-HP Centre, Paris University, Paris, France.
  • Department of General and Endocrine Surgery, Lille University Hospital, Lille, France.
  • Digestive Surgery Department, Toulouse University Hospital, Toulouse, France.
  • Digestive and Endocrine Surgery Unit, Nantes University Hospital, Nantes, France.
  • Department of Hepatobiliary and Digestive Surgery and Clinical Investigation Center, Rennes University Hospital, Rennes, France.

Zitieren

APA

Karam, E., Nassar, A., Elkurdi, S., Péré, G., Freville, T., Wasielewski, E., Palen, A., Périnel, J., Lifante, J. C., Lermite, E., Marchese, U., Adham, M., Turrini, O., Sulpice, L., Régenet, N., Carrère, N., Gaujoux, S., Pattou, F., & Sauvanet, A. (2024). Enucleation for Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors Larger than 2 Centimeters Is Associated with Equivalent Morbidity and Survival Compared to Smaller Tumors: A Multi-Institutional Study. Neuroendocrinology, 114(11), 1034-1044. https://doi.org/10.1159/000541078

Vancouver

Karam E, Nassar A, Elkurdi S, Péré G, Freville T, Wasielewski E, et al. Enucleation for Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors Larger than 2 Centimeters Is Associated with Equivalent Morbidity and Survival Compared to Smaller Tumors: A Multi-Institutional Study. Neuroendocrinology. 2024;114(11):1034-1044. doi:10.1159/000541078

BibTeX
@article{Karam2024,
  author = {Karam, Elias and Nassar, Alexandra and Elkurdi, Sara and Péré, Guillaume and Freville, Thomas and Wasielewski, Edouard and Palen, Anaïs and Périnel, Julie and Lifante, Jean-Christophe and Lermite, Emilie and Marchese, Ugo and Adham, Mustapha and Turrini, Olivier and Sulpice, Laurent and Régenet, Nicolas and Carrère, Nicolas and Gaujoux, Sébastien and Pattou, François and Sauvanet, Alain},
  title = {Enucleation for Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors Larger than 2 Centimeters Is Associated with Equivalent Morbidity and Survival Compared to Smaller Tumors: A Multi-Institutional Study},
  journal = {Neuroendocrinology},
  year = {2024},
  volume = {114},
  number = {11},
  pages = {1034--1044},
  doi = {10.1159/000541078}
}
Kostenlos starten →